Skip to main content
JBIO logo
JBIO
(NASDAQ)
Jade Biosciences, Inc.
$19.62-- (--)
Loading... - Market loading

Jade Biosciences, Inc. (JBIO) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Jade Biosciences, Inc. stock.

Analyst Consensus Rating

Investment consensus from 11 professional research analysts

Consensus Rating

Buy
Based on 11 unique analysts
(13 total ratings in last 90 days)
High Confidence:1 Buy/Sell

Average Price Target

$48.50
147.20% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest JBIO Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Laura Chico
Wedbush
BuyMaintains
-
Michael Yee
UBS
BuyInitiates
$45.00
Rami Katkhuda
LifeSci Capital
BuyMaintains
$24.00 $42.00
Laura Chico
Wedbush
BuyMaintains
$34.00 $45.00
Vamil Divan
Guggenheim
BuyReiterates
$32.00 $47.00
Julian Harrison
BTIG
BuyMaintains
$39.00 $74.00
Vamil Divan
Guggenheim
BuyReiterates
$32.00 $47.00
Arthur He CFA
HC Wainwright
BuyReiterates
$55.00
Matt Phipps
William Blair
BuyMaintains
-
Akash Tewari
Jefferies
BuyMaintains
$40.00
Tyler Van Buren
TD Cowen
BuyMaintains
-
Alex Thompson CFA
Stifel Nicolaus
BuyMaintains
$40.00
Arthur He
HC Wainwright
Strong BuyMaintains
$35.00 $45.00

Frequently Asked Questions

What is the analyst consensus rating for JBIO?

The analyst consensus rating for JBIO is "Buy" based on 11 analyst recommendations.

What is the average price target for JBIO?

The average 12-month price target for JBIO is $48.50, representing an upside of 147.2% from the current price of $19.62.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.